AstraZeneca - Oncology Pipeline AstraZeneca - Oncology Pipeline
  • Home
  • Tumor Type
  • Cell Pathway
  • Scientific Pillars
  • Glossary

Browse by Cell Pathway

  • Tumor Cell
    Tumor CellCell
    DDR Overview
    CellDDR Overview
  • Dendritic Cell
    Dendritic CellCell
  • T Cell
    B CellCell
  • T Cell
    T CellCell
  • B CellB Cell
  • Tumor CellTumor Cell
  • T CellT Cell
  • Dendritic CellDendritic Cell
  • DDR OverviewDDR Overview

Some compounds herein refer to selected AstraZeneca pipeline products still under development. AstraZeneca pipeline products are investigational products and, as such, are not approved by the US Food & Drug Administration (FDA), the European Medicines Agency (EMA) or any other regulatory agency for the uses under investigation. Information regarding these investigational products should, under no circumstances, be regarded as a recommendation for their use or of their safety or efficacy.

This site is intended for US Healthcare Professionals.

Veeva ID: Z4-80919 US-109129 DE-92568 Last Updated April 20263/26
©2026 AstraZeneca. All rights reserved.

  • Privacy Notice
  • |
  • Legal Terms of Use
  • |
  • Cookie Notice
  • Cookie Notice
  • |
  • Contact Us
  • Contact Us